FDA approves Lipfendra, Merck's new daily pill to fight bad cholesterol

Merck has received FDA approval for Lipfendra, a once-daily pill and PCSK9 inhibitor that can treat high LDL cholesterol as an alternative or complement to statins. Statins are the most prescribed medication in the US but can cause muscle aches and sometimes fail to lower cholesterol enough. Lipfendra offers a new option for patients who struggle with statin therapy.